F. Hoffmann-La Roche AG;Centre National de la Recherche Scientifique;Institut Pasteur;Commissariat à l'Énergie Atomique et aux Énergies Alternatives
发明人:
申请号：
EP14808730.7
公开号：
EP3068799B1
申请日:
2014.11.13
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to variable domain of a camelid heavy-chain antibodies directed to amyloid ² and conjugates thereof. The present invention also relates to the use of these antibody conjugates for treating or diagnosing disorders mediated by amyloid ² deposits.
